L-arabinose plus chromium for controlling the metabolization of sucrose

摘要

A composition is provided for use in decreasing metabolization of sucrose in a diabetic or obese host. The composition comprises, as the active ingredients, 500 mg to 1000 mg L-Arabinose and 100 µg to 200 µg chromium. The composition is also provided for use in inhibiting glycemic response to a meal containing sucrose in a diabetic or obese host.